title: Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.
authors.forename: Michal R
authors.initials: MR
authors.lastname: Pijak
authors.forename: Frantisek
authors.initials: F
authors.lastname: Gazdik
authors.forename: Stefan
authors.initials: S
authors.lastname: Hrusovsky
mesh_terms: D001741:Black or African American; D000998:Antiviral Agents / Q000627:therapeutic use*; D016174:Hepacivirus / Q000145:classification*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012367:RNA, Viral / Q000032:analysis; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a